Platzbecker U - Search Results

1

Longitudinal Outcome over Two Decades of Unrelated Allogeneic Stem Cell Transplantation for Relapsed/Refractory Acute Myeloid Leukemia: An ALWP/EBMT Analysis.

Nagler A, Ngoya M, Galimard JE, Labopin M, Bornhäuser M, Stelljes M, Finke J, Ganser A, Einsele H, Kröger N, Brecht A, Bethge W, Edinger M, Kulagin A, Passweg J, Blau IW, Elmaagacli A, Schäfer-Eckart K, Platzbecker U, Schroeder T, Bunjes D, Tischer J, Martin S, Spyridonidis A, Giebel S, Savani B, Mohty M. Nagler A, et al. Among authors: platzbecker u. Clin Cancer Res. 2022 Oct 3;28(19):4258-4266. doi: 10.1158/1078-0432.CCR-22-0809. Clin Cancer Res. 2022. PMID: 35670780

2

Dose-reduced conditioning for allogeneic blood stem cell transplantation: durable engraftment without antithymocyte globulin.

Bornhäuser M, Thiede C, Schuler U, Platzbecker U, Freiberg-Richter J, Helwig A, Plettig R, Röllig C, Naumann R, Kroschinsky F, Neubauer A, Ehninger G. Bornhäuser M, et al. Among authors: platzbecker u. Bone Marrow Transplant. 2000 Jul;26(2):119-25. doi: 10.1038/sj.bmt.1702500. Bone Marrow Transplant. 2000. PMID: 10918420

3

Acute heart failure after allogeneic blood stem cell transplantation due to massive myocardial infiltration by cytotoxic T cells of donor origin.

Platzbecker U, Klingel K, Thiede C, Freiberg-Richter J, Schuh D, Ehninger G, Kandolf R, Bornhäuser M. Platzbecker U, et al. Bone Marrow Transplant. 2001 Jan;27(1):107-9. doi: 10.1038/sj.bmt.1702744. Bone Marrow Transplant. 2001. PMID: 11244447

4

Early allogeneic blood stem cell transplantation after modified conditioning therapy during marrow aplasia: stable remission in high-risk acute myeloid leukemia.

Platzbecker U, Thiede C, Freiberg-Richter J, Röllig C, Helwig A, Schäkel U, Mohr B, Schaich M, Ehninger G, Bornhäuser M. Platzbecker U, et al. Bone Marrow Transplant. 2001 Mar;27(5):543-6. doi: 10.1038/sj.bmt.1702819. Bone Marrow Transplant. 2001. PMID: 11313690

5

Treatment of relapsing leukemia after allogeneic blood stem cell transplantation by using dose-reduced conditioning followed by donor blood stem cells and GM-CSF.

Platzbecker U, Thiede C, Freiberg-Richter J, Helwig A, Mohr B, Prange G, Füssel M, Köhler T, Ehninger G, Bornhäuser M. Platzbecker U, et al. Ann Hematol. 2001 Mar;80(3):144-9. doi: 10.1007/s002770000258. Ann Hematol. 2001. PMID: 11320898

6

Successful preemptive cidofovir treatment for CMV antigenemia after dose-reduced conditioning and allogeneic blood stem cell transplantation.

Platzbecker U, Bandt D, Thiede C, Helwig A, Freiberg-Richter J, Schuler U, Plettig R, Geissler G, Rethwilm A, Ehninger G, Bornhäuser M. Platzbecker U, et al. Transplantation. 2001 Apr 15;71(7):880-5. doi: 10.1097/00007890-200104150-00010. Transplantation. 2001. PMID: 11349720

7

Pharmacokinetics of intravenous mycophenolate mofetil after allogeneic blood stem cell transplantation.

Jenke A, Renner U, Richte M, Freiberg-Richter J, Platzbecker U, Helwig A, Thiede HM, Schäfer-Eckart K, Ehninger G, Bornhäuser M. Jenke A, et al. Among authors: platzbecker u. Clin Transplant. 2001 Jun;15(3):176-84. doi: 10.1034/j.1399-0012.2001.150306.x. Clin Transplant. 2001. PMID: 11389708 Clinical Trial.

8

Dose-reduced conditioning and allogeneic hematopoietic stem cell transplantation from unrelated donors in 42 patients.

Bornhäuser M, Thiede C, Platzbecker U, Jenke A, Helwig A, Plettig R, Freiberg-Richter J, Röllig C, Geissler G, Lutterbeck K, Oelschlagel U, Ehninger G. Bornhäuser M, et al. Among authors: platzbecker u. Clin Cancer Res. 2001 Aug;7(8):2254-62. Clin Cancer Res. 2001. PMID: 11489799 Clinical Trial.

9

Double lumen port access in patients receiving allogeneic blood stem cell transplantation.

Platzbecker U, Illmer T, Schaich M, Freiberg-Richter J, Helwig A, Plettig R, Jenke A, Ehninger G, Bornhäuser M. Platzbecker U, et al. Bone Marrow Transplant. 2001 Dec;28(11):1067-72. doi: 10.1038/sj.bmt.1703285. Bone Marrow Transplant. 2001. PMID: 11781618 Clinical Trial.

10

Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis.

Thiede C, Steudel C, Mohr B, Schaich M, Schäkel U, Platzbecker U, Wermke M, Bornhäuser M, Ritter M, Neubauer A, Ehninger G, Illmer T. Thiede C, et al. Among authors: platzbecker u. Blood. 2002 Jun 15;99(12):4326-35. doi: 10.1182/blood.v99.12.4326. Blood. 2002. PMID: 12036858 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

571 results

Search Page